(2014) Antimicrobial Resistance: Global Report on Surveillance, , http://www.who.int/drugresistance/documents/surveillancereport/en/, World Health Organisation (accessed 2 February 2017; O'Neill, J., (2014) Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, , https://amr-review.org/; Korzybski, T., Kowszyk-Gindifer, Z., Kurylowicz, W., (1967) Antibiotics: Origin, Nature and Properties, , Pergamon Press, Poland; D'Costa, V.M., King, C.E., Kalan, L., Morar, M., Sung, W.W., Schwarz, C., Antibiotic resistance is ancient (2011) Nature, 477, pp. 457-461; Goossens, H., Ferech, M., Vander Stichele, R., Elseviers, M., Outpatient antibiotic use in Europe and association with resistance: A cross-national database study (2005) Lancet (North Am. Ed.), 365, pp. 579-587. , ESAC Project Group; Sun, L., Klein, E.Y., Laxminarayan, R., Seasonality and temporal correlation between community antibiotic use and resistance in the United States (2012) Clin. Infect. Dis., 55, pp. 687-694; O'Neill, J., (2015) Antimicrobials in Agriculture and the Environment: Reducing Unnecessary Use and Waste, , https://amr-review.org/Publications; Cuong, N., Nhung, N.T., Nghia, N.H., Mai Hoa, N.T., Trung, N.V., Thwaites, G., Antimicrobial consumption in medicated feeds in Vietnamese pig and poultry production (2016) EcoHealth, 13, pp. 490-498; Kempf, I., Jouy, E., Chauvin, C., Colistin use and colistin resistance in bacteria from animals (2016) Int. J. Antimicrob. Agents, 48, pp. 598-606; Liu, Y.-Y., Wang, Y., Walsh, T.R., Yi, L.-X., Zhang, R., Spencer, J., Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study (2016) Lancet Infect. Dis., 16, pp. 161-168; Shen, Z., Wang, Y., Shen, Y., Shen, J., Wu, C., Early emergence of mcr-1 in Escherichia coli from food-producing animals (2016) Lancet Infect. Dis., 16, p. 293; Walsh, T.R., Wu, Y., China bans colistin as a feed additive for animals (2016) Lancet Infect. Dis., 16, pp. 1102-1103; Saint, S., Kowalski, C.P., Kaufman, S.R., Hofer, T.P., Kauffman, C.A., Olmsted, R.N., Preventing hospital-acquired urinary tract infection in the United States: A national study (2008) Clin. Infect. Dis., 46, pp. 243-250; Koeman, M., Van Der Ven, A.J., Hak, E., Joore, H.C., Kaasjager, K., De Smet, A.G., Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia (2006) Am. J. Respir. Crit. Care Med., 173, pp. 1348-1355; Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C.K., Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system (2013) JAMA Intern. Med., 173, pp. 2039-2046; Loffler, C.A., MacDougall, C., Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections (2007) Expert Rev. Anti Infect. Ther., 5, pp. 961-981; Boucher, H.W., Corey, G.R., Epidemiology of methicillin-resistant Staphylococcus aureus (2008) Clin. Infect. Dis., 46, pp. S344-S349; Lowy, F.D., Staphylococcus aureus infections (1998) N. Engl. J. Med., 339, pp. 520-532; Wertheim, H.F., Melles, D.C., Vos, M.C., Van Leeuwen, W., Van Belkum, A., Verbrugh, H.A., The role of nasal carriage in Staphylococcus aureus infections (2005) Lancet Infect. Dis., 5, pp. 751-762; Gould, F.K., Brindle, R., Chadwick, P.R., Fraise, A.P., Hill, S., Nathwani, D., Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom (2009) J. Antimicrob. Chemother., 63, pp. 849-861; Tong, M.J., Septic complications of war wounds (1972) JAMA, 219, pp. 1044-1047; Swann, J.P., The search for synthetic penicillin during World War II (1983) Brit. J. Hist. Sci., 16, pp. 154-190; Hao, H., Dai, M., Wang, Y., Huang, L., Yuan, Z., Key genetic elements and regulation systems in methicillin-resistant Staphylococcus aureus (2012) Future Microbiol., 7, pp. 1315-1329; Stapleton, P.D., Taylor, P.W., Methicillin resistance in Staphylococcus aureus: Mechanisms and modulation (2002) Sci. Prog., 85, pp. 57-72; Chambers, H.F., Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications (1997) Clin. Microbiol. Rev., 10, pp. 781-791; Stevens, D.L., The role of vancomycin in the treatment paradigm (2006) Clin. Infect. Dis., 42, pp. S51-S57; Moellering, R.C., Vancomycin: A 50-year reassessment (2006) Clin. Infect. Dis., 42, pp. S3-S4; Arthur, M., Courvalin, P., Genetics and mechanisms of glycopeptide resistance in enterococci (1993) Antimicrob. Agents Chemother., 37, pp. 1563-1571; Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T., Tenover, F., Methicillin-resistance Staphylococcus aureus clinical strain with reduced vancomycin susceptibility (1997) J. Antimicrob. Chemother., pp. 135-136; Tenover, F.C., Biddle, J.W., Lancaster, M.V., Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus (2001) Emerg. Infect. Dis., 7, pp. 327-332; Dhand, A., Sakoulas, G., Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): Implications for therapy (2012) F1000 Med. Rep., 4, p. 180; Gardete, S., Tomasz, A., Mechanisms of vancomycin resistance in Staphylococcus aureus (2014) J. Clin. Invest., 124, pp. 2836-2840; Rishishwar, L., Kraft, C.S., Jordan, I.K., Population genomics of reduced vancomycin susceptibility in Staphylococcus aureus (2016) MSphere, 1, p. e0009416; Handwerger, S., Skoble, J., Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium (1995) Antimicrob. Agents Chemother., 39, pp. 2446-2453; Burnett, Y.J., Echevarria, K., Traugott, K.A., Ceftaroline as salvage monotherapy for persistent MRSA bacteremia (2016) Ann. Pharmacother., 50, pp. 1051-1059; Miller, W.R., Bayer, A.S., Arias, C.A., Mechanism of action and resistance to daptomycin in Staphylococcus aureus and Enterococci (2016) CSH Perspect. Med., 6, p. a026997; Zeng, D., Debabov, D., Hartsell, T.L., Cano, R.J., Adams, S., Schuyler, J.A., Approved glycopeptide antibacterial drugs: Mechanism of action and resistance (2016) CSH Perspect. Med., 6; Chan, L.C., Basuino, L., Diep, B., Hamilton, S., Chatterjee, S.S., Chambers, H.F., Ceftobiprole-and ceftaroline-resistant methicillin-resistant Staphylococcus aureus (2015) Antimicrob. Agents Chemother., 59, pp. 2960-2963; Skiest, D.J., Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin (2006) J. Clin. Microbiol., 44, pp. 655-656; Syed, Y.Y., Scott, L.J., Oritavancin: A review in acute bacterial skin and skin structure infections (2015) Drugs, 75, pp. 1891-1902; McKenna, M., Apocalypse pig: The last antibiotic begins to fail (2015) Germination, National Geographic, , http://phenomena.nationalgeographic.com/2015/11/21/mcr-gene-colistin/; Cai, Y., Chai, D., Wang, R., Liang, B., Bai, N., Colistin resistance of Acinetobacter baumannii: Clinical reports, mechanisms and antimicrobial strategies (2012) J. Antimicrob. Chemother., 67, pp. 1607-1615; Gallardo-Godoy, A., Muldoon, C., Becker, B., Elliott, A.G., Lash, L.H., Huang, J.X., Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B (2016) J. Med. Chem., 59, pp. 1068-1077; Gurjar, M., Colistin for lung infection: An update (2015) J. Intensive Care, 3, p. 1; Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., Rolain, J.-M., Colistin: An update on the antibiotic of the 21st century (2012) Expert Rev. Anti Infect. Ther., 10, pp. 917-934; Olaitan, A.O., Morand, S., Rolain, J.-M., Mechanisms of polymyxin resistance: Acquired and intrinsic resistance in bacteria (2014) Front. Microbiol., 5, p. 643; Needham, B.D., Trent, M.S., Fortifying the barrier: The impact of lipid A remodelling on bacterial pathogenesis (2013) Nat. Rev. Microbiol., 11, pp. 467-481; Zavascki, A.P., Goldani, L.Z., Li, J., Nation, R.L., Polymyxin B for the treatment of multidrug-resistant pathogens: A critical review (2007) J. Antimicrob. Chemother., 60, pp. 1206-1215; Bergen, P.J., Landersdorfer, C.B., Lee, H.J., Li, J., Nation, R.L., Old' antibiotics for emerging multidrug-resistant bacteria (2012) Curr. Opin. Infect. Dis., 25, pp. 626-633; Velkov, T., Roberts, K.D., Nation, R.L., Thompson, P.E., Li, J., Pharmacology of polymyxins: New insights into an 'old' class of antibiotics (2013) Future Microbiol., 8, pp. 711-724; Li, J., Rayner, C., Nation, R., Deans, R., Boots, R., Widdecombe, N., Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration (2005) Antimicrob. Agents Chemother., 49, pp. 4814-4815; Rhouma, M., Beaudry, F., Letellier, A., Resistance to colistin: What is the fate for this antibiotic in pig production? (2016) Int. J. Antimicrob. Agents, 48, pp. 119-126; Hu, Y., Liu, F., Lin, I.Y., Gao, G.F., Zhu, B., Dissemination of the mcr-1 colistin resistance gene (2016) Lancet Infect. Dis., 16, pp. 146-147; Johnson, A.P., Woodford, N., Global spread of antibiotic resistance: The example of New Delhi metallo-Î²-lactamase (NDM)-mediated carbapenem resistance (2013) J. Med. Microbiol., 62, pp. 499-513; Davies, J., Davies, D., Origins and evolution of antibiotic resistance (2010) Microbiol. Mol. Biol. Rev., 74, pp. 417-433; Ni, W., Li, Y., Guan, J., Zhao, J., Cui, J., Wang, R., Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant Gram-negative bacteria (2016) Antimicrob. Agents Chemother., 60, pp. 3215-3218; Goli, H.R., Nahaei, M.R., Rezaee, M.A., Hasani, A., Kafil, H.S., Aghazadeh, M., Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran (2016) Iranian J. Microbiol., 8, pp. 62-69; Schwarz, S., Johnson, A.P., Transferable resistance to colistin: A new but old threat (2016) J. Antimicrob. Chemother., 71, pp. 2066-2070; Gieraltowski, L., Higa, J., Peralta, V., Green, A., Schwensohn, C., Rosen, H., National outbreak of multidrug resistant Salmonella heidelberg infections linked to a single poultry company (2016) PLoS ONE, 11, p. e016236; Van Boeckel, T.P., Brower, C., Gilbert, M., Grenfell, B.T., Levin, S.A., Robinson, T.P., Global trends in antimicrobial use in food animals (2015) Proc. Natl. Acad. Sci. U.S.A., 112, pp. 5649-5654; Aarestrup, F.M., Wegener, H.C., Collignon, P., Resistance in bacteria of the food chain: Epidemiology and control strategies (2008) Expert Rev. Anti Infect. Ther., 6, pp. 733-750; Verraes, C., Van Boxstael, S., Van Meervenne, E., Van Coillie, E., Butaye, P., Catry, B., Antimicrobial resistance in the food chain: A review (2013) Int. J. Environ. Res. Pub. Health, 10, pp. 2643-2669; Marshall, B.M., Levy, S.B., Food animals and antimicrobials: Impacts on human health (2011) Clin. Microbiol. Rev., 24, pp. 718-733; Poole, K., Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms (2001) J. Mol. Microbiol. Biotechnol., 3, pp. 255-264; Ohene-Agyei, T., Lea, J.D., Venter, H., Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets (2012) FEMS Microbiol. Lett., 333, pp. 20-27; Sarmah, A.K., Meyer, M.T., Boxall, A.B., A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment (2006) Chemosphere, 65, pp. 725-759; Webber, M., Piddock, L., The importance of efflux pumps in bacterial antibiotic resistance (2003) J. Antimicrob. Chemother., 51, pp. 9-11; Venter, H., Mowla, R., Ohene-Agyei, T., Ma, S., RND-type drug efflux pumps from Gram-negative bacteria: Molecular mechanism and inhibition (2015) Front. Microbiol., 6, p. 377; (2015) Global Action Plan on Antimicrobial Resistance, , World Health Organisation Geneva, Switzerland; (2015) Responding to the Threat of Antimicrobial Resistance: National Antimicrobial Resistance Strategy 2015-2019, , Australian Government, June (2015; McNamara, P.J., Levy, S.B., Triclosan: An instructive tale (2016) Antimicrob. Agents Chemother., pp. 2105-2116; Giuliano, C.A., Rybak, M.J., Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: A focused review (2015) Pharmacotherapy: J. Hum. Pharmacol. Drug Ther., 35, pp. 328-336; Yee, A.L., Gilbert, J.A., Is triclosan harming your microbiome? (2016) Science, 353, pp. 348-349; Webber, M.A., Whitehead, R.N., Mount, M., Loman, N.J., Pallen, M.J., Piddock, L.J., Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure (2015) J. Antimicrob. Chemother., 70, pp. 2241-2248; Suller, M., Russell, A., Triclosan and antibiotic resistance in Staphylococcus aureus (2000) J. Antimicrob. Chemother., 46, pp. 11-18; Chuanchuen, R., Karkhoff-Schweizer, R.R., Schweizer, H.P., High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux (2003) Am. J. Infect. Control., 31, pp. 124-127; Silver, S., Phung, L.T., Bacterial heavy metal resistance: New surprises (1996) Ann. Rev. Microbiol., 50, pp. 753-789; Piddock, L.J., Multidrug-resistance efflux pumps -not just for resistance (2006) Nat. Rev. Microbiol., 4, pp. 629-636; Du, D., Venter, H., Pos, K.M., Luisi, B.F., The machinery and mechanisms of multidrug efflux in Gram-negative bacteria (2013) Micrbial Efflux Pumps, pp. 35-49. , (Yu, E., Zhang, Q. and Brown, M., eds), Caister Academic Press, Norfolk, U.K; Wang, Y., Venter, H., Ma, S., Efflux pump inhibitors: A novel approach to combat efflux-mediated drug resistance in bacteria (2016) Curr. Drug Targets, 17, pp. 702-719; Blanco, P., Hernando-Amado, S., Reales-Calderon, J.A., Corona, F., Lira, F., Alcalde-Rico, M., Bacterial multidrug efflux pumps: Much more than antibiotic resistance determinants (2016) Microorganisms, 4, p. 14; Abuzaid, A., Hamouda, A., Amyes, S., Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qac?E and qacE efflux pump genes and antibiotic resistance (2012) J. Hosp. Infect., 81, pp. 87-91; Mc Cay, P.H., Ocampo-Sosa, A.A., Fleming, G.T., Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture (2010) Microbiology, 156, pp. 30-38; Baker-Austin, C., Wright, M.S., Stepanauskas, R., McArthur, J., Co-selection of antibiotic and metal resistance (2006) Trends Microbiol., 1, pp. 176-182; Kovacevic, J., Ziegler, J., Waecka-Zacharska, E., Reimer, A., Kitts, D.D., Gilmour, M.W., Tolerance of Listeria monocytogenes to quaternary ammonium sanitizers is mediated by a novel efflux pump encoded by emrE (2016) Appl. Environ. Microbiol., 82, pp. 939-953; Ho, C.-M., Li, C.-Y., Ho, M.-W., Lin, C.-Y., Liu, S.-H., Lu, J.-J., High rate of qacA-and qacB-positive methicillin-resistant Staphylococcus aureus isolates from chlorhexidine-impregnated catheter-related bloodstream infections (2012) Antimicrob. Agents Chemother., 56, pp. 5693-5697; Johnson, R.C., Schlett, C.D., Crawford, K., Lanier, J.B., Merrell, D.S., Ellis, M.W., Recurrent methicillin-resistant Staphylococcus aureus cutaneous abscesses and selection of reduced chlorhexidine susceptibility during chlorhexidine use (2015) J. Clin. Microbiol., 53, pp. 3677-3682; Kampf, G., Acquired resistance to chlorhexidine -is it time to establish an 'antiseptic stewardship' initiative? (2016) J. Hosp. Infect., 94, pp. 213-227; Kawamura-Sato, K., Wachino, J.-I., Kondo, T., Ito, H., Arakawa, Y., Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species (2010) J. Antimicrob. Chemother., 65, pp. 1975-1983; McNeil, J.C., Kok, E.Y., Vallejo, J.G., Campbell, J.R., Hulten, K.G., Mason, E.O., Clinical and molecular features of decreased chlorhexidine susceptibility among nosocomial Staphylococcus aureus isolates at Texas Children's Hospital (2016) Antimicrob. Agents Chemother., 60, pp. 1121-1128; Wu, D., Lu, R., Chen, Y., Qiu, J., Deng, C., Tan, Q., Study of cross-resistance mediated by antibiotics, chlorhexidine and Rhizoma coptidis in Staphylococcus aureus (2016) J. Glob. Antimicrob. Resist., 7, pp. 61-66; Zhang, M., O'Donoghue, M., Ito, T., Hiramatsu, K., Boost, M., Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong (2011) J. Hosp. Infect., 78, pp. 113-117; McDonnell, G., Russell, A.D., Antiseptics and disinfectants: Activity, action, and resistance (1999) Clin. Microbiol. Rev., 12, pp. 147-179; Swan, J.T., Ashton, C.M., Bui, L.N., Pham, V.P., Shirkey, B.A., Blackshear, J.E., Effect of chlorhexidine bathing every other day on prevention of hospital-acquired infections in the surgical ICU: A single-center, randomized controlled trial (2016) Crit. Care Med., 44, pp. 1822-1832; Supranoto, S., Slot, D., Addy, M., Van Der Weijden, G., The effect of chlorhexidine dentifrice or gel versus chlorhexidine mouthwash on plaque, gingivitis, bleeding and tooth discoloration: A systematic review (2015) Int. J. Dent. Hyg., 13, pp. 83-92; Lewis, S.R., Butler, A.R., Evans, D.J., Alderson, P., Smith, A.F., (2016) Chlorhexidine Bathing of the Critically Ill for the Prevention of Hospital-Acquired Infection., , The Cochrane Library; Wand, M.E., Bock, L.J., Bonney, L.C., Sutton, J.M., Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine (2016) Antimicrob. Agents Chemother., 60, pp. e01162-e01216; Bock, L., Wand, M., Sutton, J., Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains (2016) J. Hosp. Infect., 93, pp. 42-48; Saleem, H.G.M., Seers, C.A., Sabri, A.N., Reynolds, E.C., Dental plaque bacteria with reduced susceptibility to chlorhexidine are multidrug resistant (2016) BMC Microbiol., 16, p. 214; Brooks, S.E., Walczak, M.A., Hameed, R., Coonan, P., Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine (2002) Infect. Cont. Hosp. Epidemiol., 23, pp. 692-695; Bhardwaj, P., Ziegler, E., Palmer, K.L., Chlorhexidine induces VanA-type vancomycin resistance genes in enterococci (2016) Antimicrob. Agents Chemother., 60, pp. 2209-2221